David Nauman

David Nauman PhD


Executive Summary

David Nauman obtains, evaluates and advises on patent protection in the Vancouver office of Borden Ladner Gervais LLP. His areas of specialty include:

  • Drafting and prosecuting patent applications in fields related to biotechnology, life sciences, pharmaceuticals, therapeutics, medical devices, chemistry, and oil and gas.
  • Advising on patentability, validity, infringement and freedom-to-operate issues.
  • Advising on international patent strategies and portfolio management. 

After graduate school, David had the opportunity to work at the Children’s Hospital of Eastern Ontario as a research associate, and at a start-up biotechnology company in Ottawa. He has conducted research in the areas of synthetic organic chemistry, cell-surface remodelling, and molecular and cellular biology.

David passed the Canadian Patent Agent exams in 2009, and has been involved in obtaining patent protection on behalf of corporate, government and academic clients in the life sciences and manufacturing sectors.

Representative Work

  • Drafted life science-related patent applications for coated stents for treating atherosclerosis, protein sequences for organ regeneration, formulations to reduce drug abuse, MRI imaging compounds, anti-cancer vaccines and cholesterol reducing compounds.
  • Drafted patent applications related to anesthetic gas recovery systems, ozone-based disinfecting systems, water desalination systems, hydrogels, methods for recovery of metals from mining residues, and methods for plating coins.
  • Managed global patent portfolios related to vaccine formulation and development, devices for micro-extraction of biological analytes, ophthalmic diagnostic systems, ozone-based disinfecting systems, water treatment systems and anti-cancer vaccines.

Publications & Presentations

  • Co-Author, “Get a Competitive Advantage through Patent Database Mining,” Renewable Energy and Cleantech Canada, 2011.
  • Contributing Author, Life Sciences & Chemical Patent Practice in Canada: A Practical Guide, 3rd Edition, Borden Ladner Gervais LLP, 2011, available free of charge at www.blgbooks.com.
  • Nauman & Bertozzi, “Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting,” Biochim Biophys Acta, 2001, 1568(2):147-54.
  • Jacobs, Nauman, et al., “Metabolic labeling of glycoproteins with chemical tags through unnatural sialic acid biosynthesis,” Methods in Enzymology, 2000, 327:260-75.
  • George, Nauman, et al., “RuvAB-mediated branch migration does not involve extensive DNA opening within the RuvB hexamer,” Current Biology, 2000, 10(2):103-6.

Rankings & Recognitions

  • ​Recognized in the 2017 and 2016 editions of IAM Patent 1000 - The World's Leading Patent Practitioners (Patent Prosecution).